Bvf Inc Celldex Therapeutics, Inc. Transaction History

Bvf Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $3.16 Million - $5.75 Million	154,000 New	154,000 $4.15 Million
Q4 2020 Feb 12, 2021	SELL	$14.99 - $22.75 $46 Million - $69.8 Million	-3,066,797 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$9.65 - $15.19 $3.15 Million - $4.96 Million	326,797 Added 11.93%	3,066,797 $45.5 Million
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $4.41 Million - $36.7 Million	2,740,000 New	2,740,000 $35.6 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.23B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.